Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The intrinsic chaperone network of Arabidopsis stem cells confers protection against proteotoxic stress

  • Llamas, Ernesto
  • Torres-Montilla, Salvador
  • Lee, Hyun Ju
  • Barja, María Victoria
  • Schlimgen, Elena
  • Dunken, Nick
  • Wagle, Prerana
  • Werr, Wolfgang
  • Zuccaro, Alga
  • Vilchez, David
  • RODRIGUEZ-CONCEPCION, Manuel|||0000-0002-1280-2305
[EN] The biological purpose of plant stem cells is to maintain themselves while providing new pools of differentiated cells that form organs and rejuvenate or replace damaged tissues. Protein homeostasis or proteostasis is required for cell function and viability. However, the link between proteostasis and plant stem cell identity remains unknown. In contrast to their differentiated counterparts, we find that root stem cells can prevent the accumulation of aggregated proteins even under proteotoxic stress conditions such as heat stress or proteasome inhibition. Notably, root stem cells exhibit enhanced expression of distinct chaperones that maintain proteome integrity. Particularly, intrinsic high levels of the T-complex protein-1 ring complex/chaperonin containing TCP1 (TRiC/CCT) complex determine stem cell maintenance and their remarkable ability to suppress protein aggregation. Overexpression of CCT8, a key activator of TRiC/CCT assembly, is sufficient to ameliorate protein aggregation in differentiated cells and confer resistance to proteotoxic stress in plants. Taken together, our results indicate that enhanced proteostasis mechanisms in stem cells could be an important requirement for plants to persist under extreme environmental conditions and reach extreme long ages. Thus, proteostasis of stem cells can provide insights to design and breed plants tolerant to environmental challenges caused by the climate change., This work was supported by the European Research Council (ERC Starting Grant-677427 StemProteostasis) and the Deutsche Forschungsgemeinschaft (DFG) (Germany's Excellence Strategy CECAD, EXC 2030-390661388). This work was also supported by a Humboldt Research Fellowship for postdoctoral researchers to E. Llamas. Alga Zuccaro also thanks funding from the Deutsche Forschungsgemeinschaft (SFB-1403-414786233).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Disruption of MCL1/BOK transmembrane interaction as a novel strategy to induce cell death in tumours

  • Buffa, M.
  • Leiva, D.
  • García-Jareño, A.
  • Garcés-Flores, M.
  • Díaz, E.
  • Lucantoni, F.
  • Telechea, M.
  • Chen, L.
  • Lucendo, E.
  • Shalaby, R.
  • Lolicato, F.
  • Kulig, W.
  • García-Sáez, A.J.
  • Moreno-Bueno, G.
  • Sancho, M.
  • Orzáez-Calatayud, Mar
[EN] MCL1, an anti-apoptotic BCL-2 family member, is frequently overexpressed in multiple tumour types and correlates with poor prognosis; however, targeting its cytosolic domain to release pro-apoptotic effectors has been limited by cardiotoxicity in clinical trials. In this study, we describe a chemically mediated disruption of the MCL1/BOK transmembrane interaction that induces tumour cell death without affecting viability in 3D cardiomyocyte cultures. Molecular dynamics simulations and LUV-based assays converged to show that the MBoIN179 disrupts transmembrane dimerization, thereby restoring BOK pore formation inhibited by MCL1. In cells, interference with the MCL1/BOK transmembrane interaction promoted relocalization of BOK from the endoplasmic reticulum to mitochondria, where it engaged a BOK-dependent cell death program in both 2D and 3D breast cancer models, leading to reduced tumour growth and metastasis in vivo. Analysis of patient tumour microarrays further showed that BOK is overexpressed in aggressive breast cancer subtypes and correlates with poor prognosis. Together, these findings identify the MCL1/BOK transmembrane interaction as a tumour-selective vulnerability that can be engaged to promote antitumour responses with cardiac safety, highlighting transmembrane interactions as viable molecular targets., These results are part of the project PID2023-148234NB-I00, funded by MCIU/AEI/ 10.13039/501100011033 and ERDF/EU, project PT23/00177, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union, and the project CIPROM/2022/62, funded by the Department of Education, Culture, Universities and Employment of the Generalitat Valenciana (PROMETEO). A part of the work was also supported by grants from the Spanish Ministry of Economy and Innovation (PID2019- 104644RB-I00 -GMB-) and the Instituto de Salud Carlos III (CIBERONC, CB16/12/00295 -GMB). MB is funded by a predoctoral fellowship (GRISOLIAP/2021/132) from Generalitat Valenciana and by an EMBO Scientific Exchange Grant (11082) for a research stay in the laboratory of Ana García-Sáez. DL is funded by a predoctoral fellowship (PRDVA21475LEIV) from the Spanish Cancer Association (AECC). RS and AGS are partially funded by the Deutsche Forschungsgemeinschaft (CRC1403, project 414786233; TRR353, project 471011418). This work is also supported by grants of the Deutsche Forschungsgemeinschaft (DFG) to FL (SFB-1638/1 511488495 - Z01).